Azelastine + Fluticasone
Benefits at a glance
- Combination of the two most widely used treatments for allergic rhinitis in one drug
- Identical pump system as the proprietary drug
- License rights available for all key territories
- Development Kick-off
- Formulation Development
- Pilot BE
- Scale Up
- 6 M Stability
- Pivotal BE
The combination of the two most prevalent anti-rhinitis drugs, Azelastine and Fluticasone, has a strong evidence basis and is widely used for the treatment of seasonal nasal allergies. As a nasal spray, the product can be used on the go and without swallowing or water, therefore offering a noninvasive alternative. Azelastine + Fluticasone is also approved for long term use, offering patients with a consistent and safe treatment.
Approximately 20% of people suffering from seasonal nasal allergies. Azelastine and Fluticasone nasal spray not only offer an established and patient-friendly treatment option but can unlock a large market potential.